Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis C

  Free Subscription


12.02.2018

1 Biochem Biophys Res Commun
4 Gastroenterology
1 J Hepatol
5 J Viral Hepat
1 N Engl J Med
1 PLoS One
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. LI Z, Liu Q
    Hepatitis C virus regulates proprotein convertase subtilisin/kexin type 9 promoter activity.
    Biochem Biophys Res Commun. 2018 Jan 31. pii: S0006-291X(18)30199.
    PubMed     Text format     Abstract available


    Gastroenterology

  2. MUTZ P, Metz P, Lempp FA, Bender S, et al
    HBV Bypasses the Innate Immune Response and Does not Protect HCV From Antiviral Activity of Interferon.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30112.
    PubMed     Text format     Abstract available

  3. AGHEMO A, Colombo M
    Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30100.
    PubMed     Text format    

  4. BARRESI L, Ligresti D, Traina M
    A Challenging Diagnosis for a Biliary Stricture.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00215.
    PubMed     Text format    

  5. SERFATY L
    Clinical implications of concomitant alcohol use, obesity and viral hepatitis.
    Gastroenterology. 2016 Feb 9. pii: S0016-5085(16)00139.
    PubMed     Text format    


    J Hepatol

  6. LEMOINE M, Cooke GS
    The Egyptian hepatitis C programme: a model of HCV treatment intervention?
    J Hepatol. 2018 Jan 30. pii: S0168-8278(18)30068.
    PubMed     Text format    


    J Viral Hepat

  7. PREDA CM, Popescu CP, Baicus C, Constantinescu I, et al
    Risk of HBV reactivation in HBV+HCV coinfected patients with compensated liver cirrhosis treated with Ombitasvir, Paritaprevir/r+Dasabuvir+Ribavirin.
    J Viral Hepat. 2018 Feb 3. doi: 10.1111/jvh.12872.
    PubMed     Text format     Abstract available

  8. HEDENSTIERNA M, Nangarhari A, El-Sabini A, Weiland O, et al
    Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virologic response in chronic hepatitis C.
    J Viral Hepat. 2018 Feb 6. doi: 10.1111/jvh.12879.
    PubMed     Text format     Abstract available

  9. CORTESI PA, Belli LS, Facchetti R, Mazzarelli C, et al
    The optimal timing of Hepatitis C therapy in liver transplant eligible patients: cost-effectiveness analysis of new opportunities.
    J Viral Hepat. 2018 Feb 6. doi: 10.1111/jvh.12877.
    PubMed     Text format     Abstract available

  10. WALKER AJ, Peacock CJ, Pedergnana V, Irving WL, et al
    Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review.
    J Viral Hepat. 2018 Feb 3. doi: 10.1111/jvh.12871.
    PubMed     Text format     Abstract available

  11. LUXENBURGER H, Grass F, Baermann J, Boettler T, et al
    Differential virus-specific CD8(+) T-cell epitope repertoire in hepatitis C virus genotype 1 versus 4.
    J Viral Hepat. 2018 Feb 3. doi: 10.1111/jvh.12874.
    PubMed     Text format     Abstract available


    N Engl J Med

  12. GUPTA A, Jain P
    Calcified Spleen and Gallstones.
    N Engl J Med. 2018;378:380.
    PubMed     Text format    


    PLoS One

  13. ZAHR NM
    Peripheral TNFalpha elevations in abstinent alcoholics are associated with hepatitis C infection.
    PLoS One. 2018;13:e0191586.
    PubMed     Text format     Abstract available


    Virology

  14. HUANG K, Chen J, Xu R, Jiang X, et al
    Molecular evolution of hepatitis C virus in China: A nationwide study.
    Virology. 2018;516:210-218.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: